News

Biotech billionaire mounts digital attack on cancer

Dr. Patrick Soon-Shiong has taken part of his fortune made in the biotech game--via multibillion-dollar sales of his companies Abraxis and APP Pharmaceuticals--and spent it on a high-speed rail of

Scripps begins world's largest computer-based project against malaria

Malaria may have lost big when IBM's ($IBM) Watson supercomputer won Jeopardy! in February. Scientists from the Scripps Research Institute in La Jolla, CA have garnered a portion of Watson's...

Biotech heavyweight Art Levinson takes chairman job at Apple

Biotech veteran Art Levinson has served on Apple's ($AAPL) board of directors amid an incredible 11-year run, during which the tech giant has introduced the iPod, the iPhone and the iPad and has...

Gartner prescribes trial planning tools for R&D ills

Drug companies and medical device firms are searching far and wide for ways to develop new treatments without breaking the bank, and the software industry has been all too happy to point out where...

BioClinica profit slides in 3Q

BioClinica ($BIOC), a provider of clinical trials software and imaging core lab services, saw its profits fall in the third quarter. The company's GAAP net income fell from $808,000 in the third...

Dell puts cloud-computing muscle behind personalized cancer trial

As genetic analysis gobbles up large chunks of computing capacity, Dell ($DELL) has given away cloud computing tech to support research of personalized cancer treatments for kids with neuroblastoma....

BGI, Children's Hospital of Philadelphia team on next-gen sequencing, bioinformatics

BGI, the Chinese company that claims to be the largest DNA sequencing outfit, has expanded its footprint in the U.S. With its new partnership with The Children's Hospital of Philadelphia, BGI...

Foldit strategies uncovered, spotlights open R&D breakthrough

Foldit deserves its own chapter in the ongoing saga about the open R&D movement in life sciences. And if you had any doubts before-- even after players of the online protein-folding game cracked...

Y Combinator alum Comprehend lands $1.2M seed round for clinical data analytics

Comprehend Systems has some financial firepower behind the upstart's big plans to alter clinical research data analytics. The Palo Alto, CA-based firm formally announced that it has brought in $1.2

Medidata impresses with Q3 results, stock gets bump

Medidata Solutions came through with upbeat financial results for the third quarter, showing some oomph in its business of providing software for clinical researchers. The New York-based firm ($MDSO)...

Scientists building 'computer operating system' for synthetic biology

It's a truism that the pace of progress is easier to predict in information technology than in biology. Why? Living organisms are complex and not easily manipulated, for starters. But now an...

Selventa and Linguamatics team on mining details in journals

As drugmakers try to keep up with many key findings in scientific journals, personalized healthcare group Selventa and software firm Linguamatics have joined forces to streamline how important data...

Pfizer to pay big bucks for scouring databases for trials subjects

Thirteen hospitals in New York could see major investments in electronic patient records pay off in spades. Pfizer ($PFE) and four other large drug companies aim to pay the hospitals $50,000 to...

Creator of video game Foldit talks about making proteins 'toy-like'

There's been a tremendous amount of interest in making video games tools for learning rather than distractions from homework. But how does one get youths as riveted to a video game about...

Accelrys stock price dips on 3Q earnings

R&D software maker Accelrys ($ACCL) has taken a bit of hit today after reporting financial results. The San Diego-based firm has sought growth through acquisitions over the past year and a half,...

Big $125M genome center set to start in the Big Apple

As protesters occupy Wall Street, top academic groups in New York are getting ready to open one of the country's biggest genome centers in the city. With an expected price tag of $125 million,...

Suspected anti-Parkinson's gene spotted in 23andMe database

A genetic finding has triggered research that could lead to a new weapon against Parkinson's disease, a neurological disorder in dire need of new therapies. And the discovery has come from a...

10 mobile apps in Life Sciences

By Jennifer Levin Let's face it, drug developers could use the efficiency that mobile apps promise. With many big market opportunities across the life sciences industry, many firms have either

PLoS tackles bioinformatics for beginners

As computers become increasingly integrated into biological studies, the online journal PLoS Computational Biology has started publishing new articles targeting high school educators who are...

McGill U. teams with eVision to speed clinical trial starts

It's a notoriously slow process to get the regulatory sign-offs needed to begin human clinical trials in North America, and sometimes developers opt to take their studies to overseas sites where...